Compare MITI to:
After Hours:
6.63
-0.29 (-4.19%) 5:31pm ET
| Last Trade: | 6.92 |
|---|---|
| Trade Time: | Nov 25 |
| Change: | |
| Prev Close: | 6.95 |
| Open: | 6.93 |
| Bid: | 4.94 x 600 |
| Ask: | 7.50 x 500 |
| 1y Target Est: | 8.42 |
| Day's Range: | 6.78 - 7.00 |
|---|---|
| 52wk Range: | 2.25 - 8.48 |
| Volume: | 133,435 |
| Avg Vol (3m): | 370,715 |
| Market Cap: | 477.38M |
| P/E (ttm): | N/A |
| EPS (ttm): | -0.74 |
| Div & Yield: | N/A (N/A) |
| Tue, Nov 24 | Micromet Enters Into Agreement With Lonza for the Manufacture of BlinatumomabGlobeNewswire |
| Thu, Nov 12 | Micromet to Present at The Lazard Capital Markets 6th Annual Healthcare Conference on November 18, 2009GlobeNewswire |
| Wed, Nov 11 | MICROMET, INC. FinancialsEDGAR Online Financials |
| Sun, Nov 8 | New Star Analyst Rankings for Micromet, Inc.StarMine |
| Fri, Nov 6 | MICROMET, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online |
| Thu, Nov 5 | Micromet, Inc. Replay of Third Quarter 2009 Financial Results Conference Call Now AvailableGlobeNewswire |
| Thu, Nov 5 | Q3 2009 Micromet Inc. Earnings Release - 07:00 am ETCCBN |
| Thu, Nov 5 | MICROMET, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online |
| Thu, Nov 5 | Micromet, Inc. Reports Third Quarter 2009 Financial ResultsGlobeNewswire |
| Thu, Nov 5 | Micromet Buys Out MedImmune's Remaining Rights to BlinatumomabGlobeNewswire |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.